To investigate further, we established KCs by blocking the phosphorylation of K17-Ser44 using the RSK1 kinase inhibitor BI-D1870 (400 nmol/mL) (Figure 4G and Supplementary Figure 5G and 5H). The gene discussed is KRT17; the disease is dry eye syndrome.